title: Cytomegalovirus infection in a patient with atypical Kawasaki disease.
abstract: Kawasaki disease (KD) is an acute, febrile, and multisystem vasculitis of early childhood with a striking predilection for the coronary arteries. The most significant complication is coronary artery abnormalities, including coronary aneurysms. The etiology of KD remains unknown. Many infectious agents including viruses have been postulated as possible causes of KD. But standard microbiologic techniques, molecular methods and serologic investigations have failed to identify an etiologic agent. We described a patient with atypical KD during cytomegalovirus infection.
authors: Department of Pediatrics, Faculty of Medicine, Adana Teaching and Medical Research Center, Baskent University, Adana, Turkey. defneusta@hotmail.com
authors: Belgin
authors: B
authors: Usta Guc
authors: Nurcan
authors: N
authors: Cengiz
authors: Selman Vefa
authors: SV
authors: Yildirim
authors: Yasemin
authors: Y
authors: Uslu
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000914:Antibodies, Viral / Q000097:blood; D001241:Aspirin / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000235:genetics / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D004279:DNA, Viral / Q000097:blood; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D007223:Infant; D009080:Mucocutaneous Lymph Node Syndrome / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000821:virology*; D016896:Treatment Outcome; D014463:Ultrasonography
chemical_list: D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000914:Antibodies, Viral; D004279:DNA, Viral; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D002443:Ceftriaxone; D001241:Aspirin
references: Ann Dermatol Venereol. 1994;121(11):820-2
references: 7631994
references: J Pediatr. 1987 Mar;110(3):409-13
references: 3819942
references: Pediatrics. 2001 Dec;108(6):E114
references: 11731641
references: J Infect Dis. 2005 Feb 15;191(4):499-502
references: 15655771
references: Scand J Infect Dis. 2003;35(10):750-3
references: 14606615
references: Arch Mal Coeur Vaiss. 1999 Sep;92(9):1205-12
references: 10533669
references: Pathology. 1989 Oct;21(4):235-8
references: 2561192
references: Pediatr Rev. 2002 May;23(5):163-70
references: 11986492
references: J Paediatr Child Health. 2005 Mar;41(3):87-93
references: 15790316
references: Ann Rheum Dis. 1981 Aug;40(4):419-21
references: 6114714
references: Clin Infect Dis. 2005 Sep 1;41(5):e53-6
references: 16080076
references: Int J Infect Dis. 2005 Jul;9(4):185-94
references: 15936970
references: J Exp Med. 1998 Aug 3;188(3):577-88
references: 9687534
references: Rheumatol Int. 2000 Dec;20(1):35-8
references: 11149660